Trade

with

LeMaitre Vascular Inc
(NASDAQ: LMAT)
AdChoices
7.03
-0.01
-0.14%
After Hours :
-
-
-

Open

7.10

Previous Close

7.04

Volume (Avg)

7.65k (10.45k)

Day's Range

7.00-7.10

52Wk Range

6.48-8.96

Market Cap.

121.98M

Dividend Rate (Yield )

0.14 (1.92%)

Beta

0.02

Shares Outstanding

17.33M

P/E Ratio (EPS)

44.64 (0.16)

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Buy
    • Revenue

    • 64.55M

    • Net Income

    • 3.20M

    • Market Cap.

    • 121.98M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • 3.72

    • PEG (Price/Earnings Growth) Ratio

    • 1.21

    • Beta

    • 0.02

    • Forward P/E

    • 24.63

    • Price/Sales

    • 1.66

    • Price/Book Value

    • 1.80

    • Price/Cash flow

    • 30.12

      • EBITDA

      • 7.13M

      • Return on Capital %

      • 3.51

      • Return on Equity %

      • 4.15

      • Return on Assets %

      • 3.51

      • Book Value/Share

      • 3.91

      • Shares Outstanding

      • 17.33M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • 0.04 (8/19/2014)

      • Dividend Declaration Date

      • 7/29/2014

      Analyst Recommendation
      10/21/2014
      Buy
        • 1 Year Price Target

        • 10.88

        • Credit Rating

        • -

        • Analysts

        • 5

        • EPS Estimate

        • 0.29

        • Cashflow Estimate

        • 0.60

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 13.90

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • 24.50

          • -15.59

          • Net Income

            Q/Q (last year)

          • 43.10

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 5.79

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 67.92

            • 52.83

            • Pre-Tax Margin

            • 5.30

            • 15.96

            • Net Profit Margin

            • 3.72

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 71.90

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • 6.40

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • 5.40

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 5.88

              • 1.97

              • Quick Ratio

              • 3.87

              • 1.16

              • Interest Coverage

              • -

              • 10.47

              • Leverage Ratio

              • 1.19

              • 2.38

              • Book Value/Share

              • 3.91

              • 12.11

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • 43.86

                • 36.10

                • P/E Ratio 5-Year High

                • 56.86

                • 279.76

                • P/E Ratio 5-Year Low

                • 24.82

                • 148.87

                • Price/Sales Ratio

                • 1.63

                • 3.35

                • Price/Book Value

                • 1.76

                • 4.19

                • Price/Cash Flow Ratio

                • 30.12

                • 17.36

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • 4.15

                    (6.00)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • 3.51

                    (5.10)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • 4.15

                    (6.00)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • 7.58k

                  • 25.65k

                  • Inventory Turnover

                  • 1.64

                  • 2.66

                  • Asset Turnover

                  • 0.94

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  4.52M
                  Operating Margin
                  7.00
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  30.12
                  Ownership

                  Institutional Ownership

                  44.62%

                  Top 10 Institutions

                  36.61%

                  Mutual Fund Ownership

                  12.32%

                  Float

                  63.42%

                  5% / Insider Ownership

                  31.04%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Vanguard VIF Small Comp Gr

                  •  

                    352,986

                  • 0.00

                  • 2.04

                  • Satuit Capital US Emerging Companies Fd

                  •  

                    289,700

                  • 0.00

                  • 1.67

                  • Vanguard US Discoveries Fund

                  •  

                    245,098

                  • -3.88

                  • 1.42

                  • Vanguard Total Stock Mkt Idx

                  •  

                    177,521

                  • 0.00

                  • 1.02

                  • DFA U.S. Micro Cap Portfolio

                  •  

                    170,177

                  • 0.00

                  • 0.98

                  • Vanguard Extended Market Index Fund

                  •  

                    133,480

                  • 0.00

                  • 0.77

                  • DFA U.S. Small Cap Portfolio

                  •  

                    94,561

                  • 0.00

                  • 0.54

                  • DFA US Targeted Value Portfolio

                  •  

                    73,991

                  • 0.00

                  • 0.43

                  • DFA US Small Cap Value II Portfolio

                  •  

                    72,587

                  • 0.00

                  • 0.42

                  • DFA Tax-Managed U.S. Targeted Value

                  •  

                    69,901

                  • 0.00

                  • 0.40

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Awm Investment Company Inc

                  •  

                    1,311,617

                  • +320.91%

                  • 7.59

                  • Wellington Management Company, LLP

                  •  

                    934,614

                  • -5.97%

                  • 5.41

                  • Cannell Capital LLC

                  •  

                    909,539

                  • +12.35%

                  • 5.27

                  • Dimensional Fund Advisors, Inc.

                  •  

                    751,061

                  • +0.01%

                  • 4.35

                  • Granahan Investment Management Inc..

                  •  

                    723,932

                  • -2.50%

                  • 4.18

                  • Millennium Management LLC

                  •  

                    500,000

                  • +64.86%

                  • 2.89

                  • Vanguard Group, Inc.

                  •  

                    341,680

                  • +14.13%

                  • 1.98

                  • LAPIDES ASSET MANAGEMENT, LLC

                  •  

                    328,200

                  • 0.00%

                  • 1.90

                  • Satuit Capital Management, LLC

                  •  

                    289,700

                  • 0.00%

                  • 1.67

                  • First Light Asset Management, LLC

                  •  

                    236,262

                  • +5.75%

                  • 1.37

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Classic Growth

                  Style

                  Small Growth

                  LeMaitre Vascular, Inc., was incorporated in Massachusetts on November 28, 1983, as Vascutech, Inc. On April 6, 2001, the Company changed its name to LeMaitre Vascular, Inc. The Company is a provider of medical devices and implants f...moreor the treatment of peripheral vascular disease. It develops, manufactures, and markets vascular devices to address the needs of vascular surgeons. Its diversified portfolio of peripheral vascular devices consists of brand name products that are used in arteries and veins outside of the heart and are well known to vascular surgeons, including the Expandable LeMaitre Valvulotome, the Pruitt F3 Carotid Shunt, VascuTape Radiopaque Tape and the XenoSure biologic patch. Its products are used by vascular surgeons who treat peripheral vascular disease through both open surgical...more methods and endovascular techniques. In contrast to interventional cardiologists and interventional radiologists, neither of whom are certified to perform open surgical procedures, vascular surgeons can perform both open surgical and minimally invasive endovascular procedures, and are therefore positioned to provide treatment options to patients. The principal product lines include the following: valvulotomes, balloon catheters, carotid shunts, biologic vascular patches, radiopaque marking tape, anastomotic clips, remote endarterectomy devices, laparoscopic cholecystectomy devices, vascular grafts, and powered phlebectomy. It has completed fourteen acquisitions of complementary products since 1998. The Company also sells non-vascular medical devices used in general surgery procedures, primarily laparoscopic cholecystectomy. Its leading general surgery product is the Reddick Cholangiogram Catheter, which is used to inject dye into the cystic duct during laparoscopic cholecystectomy. In this procedure, the gall bladder is dissected and removed through small punctures in the abdomen. It also offers two laparoscopic accessories used in laparoscopic gall bladder removal. Notable competitors of the Company include Applied Medical Resources Corporation, Baxter International, Inc., Cardiovascular Systems, Inc., C.R. Bard, Inc., Edwards Lifesciences Corporation, Getinge AB, Jotec GmbH, SAS Perouse Medical, Terumo Medical Corporation, Uresil, LLC, and W. L. Gore & Associates. It relies on a combination of patents, trademarks, trade secret laws, and confidentiality and invention assignment agreements to protect its intellectual property rights. The products are medical devices subject to extensive regulation by the FDA under the Federal Food, Drug, and Cosmetic Act (the FDCA).lessless

                  Key People

                  George W. Lemaitre

                  CEO/Chairman of the Board/Director

                  Joseph P. Pellegrino,Jr

                  CFO/Chief Accounting Officer/Secretary

                  Cornelia W. Lemaitre

                  Director/Vice President, Divisional

                  Kimberly L. Cieslak

                  Vice President, Divisional

                  Jonathan W. Ngau

                  Vice President, Divisional

                  • LeMaitre Vascular Inc

                  • 63 2nd Avenue

                  • Burlington, MA 01803

                  • USA.Map

                  • Phone: +1 781 221-2266

                  • Fax: +1 781 425-5049

                  • lemaitre.com

                  Incorporated

                  1983

                  Employees

                  334

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: